Amvis Holdings.Inc. (7071) AI Stock Analysis

• Market Cap: ¥43.36B
• Dividend Yield: 0.91%
• Average Volume (3M): 1.46M
• Price to Earnings (P/E): 11.8
• Beta (1Y): 1.10
• Revenue Growth: 15.77%
• EPS Growth: -50.57%
• Country: JP
• Employees: 4,046
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 98,313,600
• 10 Day Avg. Volume: 829,320
• 30 Day Avg. Volume: 1,455,976
• PEG Ratio: -0.32
• Price to Book (P/B): 1.63
• Price to Sales (P/S): 1.19
• P/FCF Ratio: -13.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 62 Neutral
• Price Target: ¥510.00 ▲(15.65% Upside)

Amvis Holdings Inc. receives a moderate score due to strong revenue growth but faces challenges with declining profit margins and liquidity issues. The technical indicators suggest a bearish trend, while the valuation appears reasonable. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, which are essential for long-term sustainability.

Business Model

A diversified business model allows Amvis to leverage synergies and capitalize on emerging trends, enhancing resilience and growth potential.

Market Position

By focusing on technology and innovation, Amvis is well-positioned to adapt and thrive in evolving markets, ensuring long-term competitiveness.

Negative Factors

Profit Margins

Declining profit margins suggest increased cost pressures or pricing challenges, which could impact profitability and financial health over time.

Leverage

Increased leverage can strain financial flexibility and elevate risk, especially if interest rates rise or cash flows become constrained.

Cash Flow

Negative free cash flow indicates potential liquidity issues, limiting the company's ability to invest in growth or weather economic downturns.

Amvis Holdings.Inc. Business Overview & Revenue Model

Company Description

Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Amvis Holdings generates revenue through a multi-faceted model, primarily by acquiring stakes in high-potential companies within its sectors of interest. The company earns income through dividends from its investments, capital gains from the appreciation of its holdings, and fees for services rendered by its subsidiaries. Additionally, Amvis engages in strategic partnerships that allow for collaborative projects and shared resources, further enhancing its revenue streams. Its focus on technology and innovation positions it to capitalize on emerging market trends, which can lead to significant financial returns.

Amvis Holdings.Inc. Financial Statement Overview

Summary

Amvis Holdings Inc. shows strong revenue growth and profitability margins, with a robust income statement. However, the balance sheet reveals rising debt levels, and cash flow management is a concern due to zero free cash flow in TTM, indicating potential cash generation issues.

Income Statement

Amvis Holdings Inc. demonstrates robust financial performance with steady revenue growth, as indicated by a significant TTM revenue of 44.7 billion JPY compared to 31.9 billion JPY in the previous annual period, marking a growth rate of approximately 32.8%. The gross profit margin remains strong at 38.3% in TTM, reflecting effective cost management. The net profit margin is healthy at 15.6% in TTM, though there has been a slight decline from previous periods, suggesting some pressure on net income. EBIT and EBITDA margins are also solid at 22.3% and 26.5% respectively, showcasing operational efficiency.

Balance Sheet

The balance sheet of Amvis Holdings Inc. indicates a strong equity position with a debt-to-equity ratio of 0.99 in TTM, which is manageable, though it has increased compared to previous years. The company's equity ratio stands at 45.9%, reflecting a balanced capital structure. Return on equity is impressive at 20.6% in TTM, indicating effective use of shareholder funds. However, the increased total debt level may pose potential risks if not managed carefully.

Cash Flow

Cash flow analysis reveals challenges, as the company reports a zero free cash flow in TTM, indicating issues in cash generation after investments. The operating cash flow to net income ratio is unavailable due to missing data, which makes it difficult to assess cash flow efficiency. Historical data shows a negative trend in free cash flow, highlighting the need for improved cash management.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	46.70B	49.17B	42.48B	31.98B	23.07B	15.33B
Gross Profit	16.71B	14.79B	17.06B	13.27B	9.69B	6.30B
EBITDA	11.56B	9.02B	12.76B	10.39B	7.10B	4.48B
Net Income	6.33B	3.66B	7.44B	6.31B	4.28B	2.63B
Balance Sheet
Total Assets	82.68B	83.95B	71.80B	55.56B	41.77B	31.92B
Cash, Cash Equivalents and Short-Term Investments	11.81B	10.83B	8.87B	12.13B	11.34B	11.19B
Total Debt	40.32B	40.15B	31.75B	23.05B	17.43B	12.75B
Total Liabilities	47.52B	47.81B	38.59B	29.04B	21.31B	15.58B
Stockholders Equity	35.16B	36.13B	33.21B	26.52B	20.46B	16.34B
Cash Flow
Free Cash Flow	0.00	-4.38B	-8.52B	-3.06B	-2.73B	-2.79B
Operating Cash Flow	0.00	6.03B	7.48B	6.80B	4.42B	2.58B
Investing Cash Flow	0.00	-10.43B	-16.83B	-10.31B	-7.75B	-5.78B
Financing Cash Flow	0.00	6.37B	6.08B	4.30B	3.49B	11.05B

Amvis Holdings.Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 441.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Neutral. The current price of 441 is below the 20-day moving average (MA) of 464.00, below the 50-day MA of 490.84, and below the 200-day MA of 516.96, indicating a neutral trend. The MACD of -10.53 indicates Negative momentum. The RSI at 50.36 is Neutral, neither overbought nor oversold. The STOCH value of 37.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7071.

Amvis Holdings.Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6099	76 Outperform	¥44.38B	17.44	20.29%	1.77%	16.49%	3.34%
6197	76 Outperform	¥77.69B	17.25	―	2.47%	1.86%	1370.48%
2374	75 Outperform	¥30.23B	17.11	―	2.48%	3.88%	0.31%
6062	72 Outperform	¥42.13B	13.81	―	2.63%	0.30%	-31.28%
9158	64 Neutral	¥25.59B	15.05	―	―	31.65%	-51.36%
7071	62 Neutral	¥43.36B	11.76	―	0.91%	15.77%	-50.57%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Amvis Holdings.Inc. Corporate Events

Amvis Holdings Revises Financial Forecast Amid Operational Disruptions

Amvis Holdings, Inc. announced corrections to its previously disclosed Consolidated Financial Summary for the first nine months of the fiscal year ending September 30, 2025, due to identified inaccuracies. The company revised its full-year earnings forecast downward, citing disruptions caused by staff reassignment for an investigation, which impacted service provision and sales.

The most recent analyst rating on (JP:7071) stock is a Buy with a Yen665.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Holdings Revises Earnings Forecast Amid Operational Challenges

Amvis Holdings, Inc. has revised its full-year earnings forecast for the fiscal year ending September 30, 2025, due to recent performance trends and operational challenges. The company anticipates a decrease in net sales, operating profit, ordinary profit, and profit attributable to owners of the parent compared to previous forecasts, largely due to staff reassignments for a special investigation, affecting service provision and occupancy adjustments.

The most recent analyst rating on (JP:7071) stock is a Buy with a Yen665.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Holdings Reports Decline in Profits Despite Sales Growth

Amvis Holdings, Inc. reported a decline in profits for the first nine months of the fiscal year ending September 30, 2025, despite an increase in net sales. The company experienced a significant decrease in EBITDA, operating profit, and profit attributable to owners of the parent, reflecting challenges in maintaining profitability. The financial forecast for the fiscal year anticipates continued pressure on profits, with a notable decrease expected in profit attributable to owners of the parent. The inclusion of a new company, Midori, in the scope of consolidation marks a strategic move, although the overall financial outlook remains cautious.

The most recent analyst rating on (JP:7071) stock is a Buy with a Yen665.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Holdings Sets New Date for Q3 Financial Results

Amvis Holdings, Inc. has announced a new date for the release of its financial results for the third quarter of the fiscal year ending September 2025, which will now be disclosed on October 17, 2025. The company had previously delayed the announcement, causing inconvenience and concern among stakeholders, for which it has apologized.

The most recent analyst rating on (JP:7071) stock is a Buy with a Yen673.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.

Amvis Holdings Announces Improvement Measures Following Investigation

Amvis Holdings, Inc. has announced a series of improvement measures following an investigation into its operations, prompted by media reports of potential improper medical fee claims. The investigation found no organizational misconduct but highlighted areas needing improvement. In response, Amvis is implementing measures to define and standardize home-visit nursing services, enhance recruitment and staffing systems, rebuild internal controls, and improve internal communication. These initiatives aim to strengthen the company’s operational efficiency and compliance, ultimately benefiting stakeholders by ensuring accurate service delivery and robust internal processes.

Amvis Holdings Completes Semi-Annual Report Submission

Amvis Holdings, Inc. has announced the completion of its semi-annual report submission for the fiscal year ending September 30, 2025, following an approved extension. The company expressed apologies for any inconvenience caused by the delay, emphasizing its commitment to maintaining transparency and accountability with its stakeholders.

Amvis Holdings Delays Third Quarter Financial Results Disclosure

Amvis Holdings, Inc. announced a delay in the disclosure of its financial results for the third quarter of the fiscal year ending September 30, 2025. The delay, expected to exceed 45 days post-quarter, is due to the time required to complete procedures related to the financial results. This postponement may cause inconvenience and concern among stakeholders, but the company assures that the specific date for the announcement will be disclosed promptly once determined.

Amvis Holdings Reports Profit Decline Amid Sales Growth

Amvis Holdings, Inc. reported a decline in profits for the first six months of the fiscal year ending September 30, 2025, despite an increase in net sales. The company’s operating profit and profit attributable to owners of the parent decreased significantly compared to the previous year, indicating challenges in maintaining profitability. The company also announced the inclusion of a new subsidiary, Midori, in its consolidated financial statements, reflecting strategic expansion efforts.

Amvis Holdings Receives Investigation Report on Billing Allegations

Amvis Holdings, Inc. has received an investigation report from a Special Investigation Committee, which was formed to examine allegations of improper billing of medical fees. The investigation found no evidence of systematic misconduct, and the financial impact is minor, amounting to approximately ¥63 million. The company acknowledges deficiencies in its internal systems and is committed to improvements, including organizational restructuring and enhanced recordkeeping. The findings have caused concern among stakeholders, and Amvis plans to disclose further initiatives at its upcoming earnings announcement.